Funding for this research was provided by:
American Cancer Society (MRSG-16-020-01-CPPB, 130741-CCCDA-17-072-01-CCCDA)
Breast Cancer Research Foundation (BCRF-19-039)
National Cancer Institute (P30 CA008748)
Basser Center for BRCA
Sharon Levine Corzine Foundation
Received: 23 March 2020
Accepted: 22 July 2020
First Online: 17 August 2020
Ethics approval and consent to participate
: Ethics approval was obtained from Advarra (ExternalRef removed), the independent Institutional Review Board utilized for all study sites, with additional oversight by study institutions. Study participants undergoing <i>BRCA1/2</i> testing provided written informed consent. Consent was implied for providers responding to the surveys.
: Not applicable.
: The authors declare that they have no competing interests.